Chronic Obstructive Pulmonary Disease

Caloric intake and muscle mass at high altitude

New research in The FASEB Journal explored why a group of young, healthy adults residing at high altitude lost muscle mass while severely underfed and consuming the same high-protein diet that preserved muscle during weight ...

Jun 07, 2018
popularity0 comments 0

Flavonoids may slow lung function decline due to aging

Previous research has shown that the plant-produced chemicals known as flavonoids have beneficial antioxidant and anti-inflammatory properties. Anthocyanins, the type of flavonoid investigated in the current study, have been ...

May 21, 2018
popularity2 comments 0

Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), chronic airflow limitation (CAL) and chronic obstructive respiratory disease (CORD), is the co-occurrence of chronic bronchitis and emphysema, a pair of commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs, causing shortness of breath (dyspnea). In clinical practice, COPD is defined by its characteristically low airflow on lung function tests. In contrast to asthma, this limitation is poorly reversible and usually gets progressively worse over time. In England, an estimated 842,100 of 50 million people have a diagnosis of COPD.

COPD is caused by noxious particles or gas, most commonly from tobacco smoking, which triggers an abnormal inflammatory response in the lung.

The diagnosis of COPD requires lung function tests. Important management strategies are smoking cessation, vaccinations, rehabilitation, and drug therapy (often using inhalers). Some patients go on to require long-term oxygen therapy or lung transplantation.

Worldwide, COPD ranked as the sixth leading cause of death in 1990. It is projected to be the fourth leading cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes in many countries. COPD is the third leading cause of death in the U.S. and the economic burden of COPD in the U.S. in 2007 was $42.6 billion in health care costs and lost productivity.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

How cannabis and cannabis-based drugs harm your brain

Long-term use of either cannabis or cannabis-based drugs impairs memory say researchers. The study has implications for both recreational users and people who use the drug to combat epilepsy, multiple sclerosis and chronic ...

Enzyme lays the foundations for allergic immune response

While in search of the causes of allergies and asthma, a chance discovery has yielded new clues: researchers led by Dr. Marcus Peters have ascertained that the enzyme guanylate cyclase in cells lays the foundations for the ...